CBD: what the science says | Brazcann

CBD (cannabidiol) is the most studied non-psychoactive cannabinoid in Cannabis. Unlike THC, it does not cause euphoria — which is why it draws much of the clinical research and health and wellness interest. This guide responsibly summarizes what science actually shows and what Brazilian regulation currently allows.

What CBD is

It is a molecule that interacts with the endocannabinoid system, involved in regulating pain, mood, sleep and inflammation. CBD is studied for anxiolytic, anti-inflammatory and antioxidant effects, and it is the active ingredient of medicines already approved by international agencies.

Where the evidence is strongest

• Severe epilepsies — cannabidiol is the basis of the medicine Epidiolex, approved for Dravet and Lennox-Gastaut syndromes, with efficacy shown in randomized clinical trials published in the New England Journal of Medicine.
• Multiple sclerosis — the THC:CBD combination (nabiximols/Sativex) is registered for spasticity.
• Active research — chronic pain, anxiety, sleep and chemotherapy nausea remain under investigation.

You can explore dozens of real studies in our scientific library, with the primary source cited in each one.

Safety and common sense

CBD is usually well tolerated, but it can have drug interactions and side effects. Any therapeutic use must start from an individualized medical assessment and prescription — this content is informative and does not replace a healthcare professional.

CBD beyond health

Beyond medicine, CBD appears in functional beverages and cosmetics where regulation allows — topics we analyze in cases like functional beverages with CBD and skincare with CBD and hemp oil.

What Brazilian regulation allows

In Brazil, cannabis health products are regulated by Anvisa — through RDC 660/2022 (patient import) and the new manufacturing and import framework, RDC 1,015/2026. Beverages and cosmetics with CBD depend on specific classification — which is why many scenarios are still strategic and forward-looking.

Frequently asked questions

Does CBD have a psychoactive effect?

No. CBD does not cause euphoria, unlike THC.

Is CBD approved for any disease?

Yes: cannabidiol is the basis of a medicine approved for severe epilepsies (Dravet and Lennox-Gastaut), with clinical-trial evidence.

Can I use CBD on my own?

No. Therapeutic use requires medical assessment and prescription; there are interactions and effects to consider.

Brazcann translates cannabis science and regulation to the Brazilian reality. Explore the science in our system and the studies library.

Informative and scientific content; it does not replace medical advice.